• 33 Citations
  • 4 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Histone Deacetylase Inhibitors Medicine & Life Sciences
Platinum Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Observational Studies Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 33 Citations
  • 4 h-Index
  • 20 Article
  • 1 Review article
1 Citations

Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology

Finocchiaro, C. Y., Rota, A., Barbieri, V., Bettini, A., Bianco, R., Borra, G., Buffoni, L., Bulotta, A., Carta, A., Cortinovis, D., Costanzo, R., Cusmai, A., Danesi, R., D'Argento, E., Del Conte, A., Franchina, T., Gilli, M., Gregorc, V., Irtelli, L., Landi, L. & 18 othersMalorgio, F., Mancuso, G., Martelli, O., Mazzanti, P., Melotti, B., Migliorino, M. R., Minotti, V., Montrone, M., Morabito, A., Roca, E., Romano, G., Rossi, A., Savio, G., Tiseo, M., Boscardini, I., Piccolo, L., Pilotto, S. & Malapelle, U., Jan 1 2019, In : Translational Cancer Research. 8, p. S16-S22

Research output: Contribution to journalArticle

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Metro, G., Passaro, A., Lo Russo, G., Bonanno, L., Giusti, R., Gregorc, V., Capelletto, E., Martelli, O., Cecere, F. L., Giannarelli, D., Luciani, A., Bearz, A., Tuzi, A., Scotti, V., Tonini, G., Galetta, D., Carta, A., Soto Parra, H., Rebonato, A., Morabito, A. & 1 othersChiari, R., 2018, In : Future Oncology. 14, 4, p. 353-361 9 p.

Research output: Contribution to journalArticle

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Metro, G., Passaro, A., Lo Russo, G., Bonanno, L., Giusti, R., Gregorc, V., Capelletto, E., Martelli, O., Cecere, FL., Giannarelli, D., Luciani, A., Bearz, A., Tuzi, A., Scotti, V., Tonini, G., Galetta, D., Carta, A., Soto Parra, H., Rebonato, A., Morabito, A. & 1 othersChiari, R., 2018, In : Future Oncology. 14, 4, p. 353-361 9 p.

Research output: Contribution to journalArticle

1 Citations

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Metro, G., Passaro, A., Lo Russo, G., Bonanno, L., Giusti, R., Gregorc, V., Capelletto, E., Martelli, O., Cecere, F. L., Giannarelli, D., Luciani, A., Bearz, A., Tuzi, A., Scotti, V., Tonini, G., Galetta, D., Carta, A., Soto Parra, H., Rebonato, A., Morabito, A. & 1 othersChiari, R., Feb 1 2018, In : Future Oncology. 14, 4, p. 353-361 9 p.

Research output: Contribution to journalArticle

Compassionate Use Trials
Non-Small Cell Lung Carcinoma
Disease-Free Survival
ceritinib
crizotinib

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

Lazzari, C., Gregorc, V., Cangi, MG., Giovannetti, E., Bulotta, A. & Santarpia, M., 2018, In : Journal of Thoracic Disease. 10, p. S4023-S4027 5 p.

Research output: Contribution to journalArticle